Perkins Coie Trust Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$655 Buy
37
+33
+825% +$557 ﹤0.01% 405
2026
Q2
$63 Hold
4
– – ﹤0.01% 243
2026
Q1
$54 Sell
4
-96
-96% -$1.34K ﹤0.01% 240
2025
Q4
$1.25K Buy
+100
New +$1.08K ﹤0.01% 251
2023
Q2
– Sell
-229
Closed -$2.2K – 250
2023
Q1
$2.2K Buy
+229
New +$2.54K ﹤0.01% 220
2021
Q3
– Sell
-76
Closed -$1K – 295
2021
Q2
$1K Buy
+76
New +$1.1K ﹤0.01% 293

Other funds holding VTRS

Perkins Coie Trust Company's VTRS Position: Q3 2026 in Review

Perkins Coie Trust Company increased its Viatris (VTRS) stake by 825% in Q3 2026, buying an estimated $557 and bringing the position to 37 shares worth $655. The position accounts for ﹤0.01% of the portfolio, ranked #405.

Perkins Coie Trust Company first reported a position in VTRS in Q2 2021 and has held it in 6 quarters since. The position peaked at $2.2K in Q1 2023. 105 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Perkins Coie Trust Company held 37 shares of Viatris worth $655 as of Q3 2026.
  • Perkins Coie Trust Company bought 33 Viatris shares in Q3 2026, an estimated $557.
  • Viatris made up ﹤0.01% of Perkins Coie Trust Company's portfolio in Q3 2026, its #405 holding.
  • Perkins Coie Trust Company first reported a position in Viatris in Q2 2021 and has held it in 6 quarters since.
  • Perkins Coie Trust Company's Viatris position peaked at $2.2K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Perkins Coie Trust Company's 13F filing for Q3 2026, filed 15 Oct 2026.